NCT00829010View on ClinicalTrials.gov

Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age.

PHASE3CompletedINTERVENTIONAL
Enrollment

489

Participants

Timeline

Start Date

February 17, 2009

Primary Completion Date

June 13, 2011

Study Completion Date

June 27, 2012

Conditions
Infections, Streptococcal
Interventions
BIOLOGICAL

Pneumococcal vaccine GSK1024850A

Intramuscular injection, administered as 3 or 4 doses

BIOLOGICAL

Tritanrix-HepB/Hib

Intramuscular injection, 4 doses

BIOLOGICAL

measles

Intramuscular injection, 2 doses

BIOLOGICAL

Rotarix

Oral, 2 doses

BIOLOGICAL

Local OPV

Oral 4 doses. Given at any time during the study, routinely given concurrently with DTPw-HBV/Hib vaccine

Trial Locations (1)

2013

GSK Investigational Site, Soweto

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY